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Introduction
The bromocresol green (BCG) method was introduced by
Rodkey [1] in 1965 for determination of serum and plasma
albumin and it is still widely used--despite criticism of the
available procedures I-2, 3, 4 and 5]. In 1976, Savory et al. [6]
adopted a method for use in centrifugal analysis demonstrating
good precision and accuracy. Although bromocresol purple has
been suggested as an alternative dye !-7 and 8], this dye is not
suitable for samples from some animal species nor for quality-
control sera (for example bovine sera). The lack of readily
available specific antisera for some animal species, and the
unsuitability of bromocresol purple, led the authors to develop
an automated BCG method using the Cobas Bio (Roche)
centrifugal analyser [9] and to compare this method with an
immunoturbidimetric method for human albumin using the
same instrument. Centrifugal analysers permit very rapid ab-
sorbance measurements to be made, thus avoiding the slower
reactions resulting from the binding of certain alpha- and
betaglobulins with BCG. The over-estimation of plasma serum
albumin at lower concentrations may be avoided by adjusting
the assay conditions.
Materials and methods
BCG method
The reagents used were as follows"
(1) Citrate buffer solution, pH 3"8, obtained from BDH
Chemicals Ltd, Poole, UK--product number 22115.
(2) Bromocrescol green, obtained from BDH Chemicals
Ltd. A solution containing 2 mg/ml BCG in the
citrate buffer solution is prepared and stored at ambient
temperature. This reagent has been found to be stable for
at least three months.
(3) Wellcomtrol Survey Validated Reference Serum from
Wellcome Diagnostics, Dartford, Kent, UK.
(4) Preciset Protein Standards (bovine albumin), obtained
from BCL, Lewes, East Sussex, UK.
The instrument settings finally chosen for the BCG method
using the Cobas Bio centrifugal analyser are presented in table 1;
this analysis programme allows for rapid absorbance measure-
ments to be made following the addition ofBCG reagent which
acts as a ’start reagent’ when added to the diluted samples.
Immunoturbidimetric method
Reagents used were:
(1) 0"9% isotonic saline.
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(2) Polyethylene glycol (PEG) Diluent 6000, obtained from
BCL, is diluted by adding 5 ml to 95 ml isotonic
saline before use.
(3) Anti-human albumin serum solution from BCL is
diluted + 60 with the diluted PEG reagent.
(4) Human albumin obtained from Calbiochem--Behring
Corporation.
The immunoturbidimetric method [10] requires that
5/1 of diluted serum or plasma (one volume of serum or
plasma plus 200 volumes ofPEG working solution) be added to
255 #1 of diluted anti-serum at 25C. The concentration values
for albumin are determined from changes in absorbance at
340nm, monitored at 10s intervals for a period of 200s. The
frequent monitoring of the reaction allows for the detection of
antigen excess reactions, and variability between different
batches of antisera and polyethylene glycol reagents. When N
18 samples, within-batch coefficients of variation of 3.82% at
30 g/1 and 3.47% at 50 g/1 were obtained.
Table 1. Cobas Bio settings usedfor the determination of
plasma albumin using bromocresol green.
(1) Units g/1
(2) Calculation factor 0
(3) Standard concentration
(4) Standard 2 concentration Assigned
(5) Standard 3 concentration value
(6) Limit 60
(7) Temperature (C) 30"0
(8) Type of analysis 6
(9) Wavelength (nm) 620
(10) Sample volume (/zl) 05
(11) Diluent volume (#1) 30
(12) Reagent volume (gl) 200
(13) Incubation time (s) 10
(14) Start reagent volume (/zl) 20
(15) Time of first reading (s) 10.0
(16) Time interval (s) 10
(17) Number of readings 01
(18) Blanking mode
(19) Print-out mode
Results
Using Preciset protein and human albumin standards, ranging
between 10 and 70g/1 in ascending and descending order of
concentration, the BCG assay was found to be linear between 20
and 60 g/l. Alterations ofthe dye concentrations caused marked
shifts in the relationship between absorbance and concentration,
resulting in either over- or under-estimation ofalbumin concen-
tration levels. Using the procedure of Broughton et al. [11],
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carry-over between samples was not evident when 20g/1 and
70 g/l standards were used to take readings, with interaction
(K)=-0"0031. When N=25 samples, within-batch CVs of
1.36 at 27 g/1 and 1.05 at 40.7 g/1 were obtained. Between-
batch reproducibility was found to be 2.45 at 27 g/1 and 2.41
at 40.7 g/1 using Wellcomtrol Survey Validated Reference Serum
(U=40).
The accuracy of the BCG method was assessed by a
comparison ofthe method values with values obtained using the
immunoturbidimetric procedure for human plasma samples,
and also with the consensus mean values found in the National
External Quality Assurance Scheme (NEQAS) and the
Wellcome Group Quality Control Programme (WGQCP).
Results obtained by BCG and immunoturbidimetric procedures
showed good agreement over the range 22-57 g/1 for 30 human
samples (see figure 1). For eight NEQAS samples distributed in
1982 and analysed on the day of reconstitution, all results were
within standard deviation of the recalculated overall mean
values, with six of the results within 0"5 SD.
For 12WGQCP samples the bias observed was 0" 119, and a
precision value of 1" 18 was obtained, compared with an overall
precision value of 1"59 for 993 laboratories. For 16 other
WGQCP samples, close agreement was also achieved where the
correlation coefficient was 0"99 (y= 1"04x-1"65).
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Figure 1. Comparison between BCG and immunoturbidi-
metric values for human samples.
Discussion
An albumin method using bromocresol green and a Cobas Bio
centifrugal analyser has been developed for use with plasma
samples from several different animal species, over the range 25
to 60g/1. The procedure shows good agreement with values
obtained by an immunoturbidimetric method. Performance of
the BCG method in assaying samples from external quality
assessment schemes was found to be acceptable. The precision of
the assay was slightly better than with the immunoturbidimetric
procedure used for this comparison, and the determined
coefficients of variation were similar to those obtained by
Izquierdo et al. [12] who used a Cobas Bio centrifugal analyser
and a succinate, rather than a citrate buffer diluent for albumin
determinations. The recent advances in laboratory analysers,
particularly centrifugal analysers, have led to improvements of
albumin determinations using bromocresol green; it is now
possible to make rapid absorbance measurements following the
addition of dye to sample, thus reducing the effect of reactions
between the dye and other protein fractions.
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FORTHCOMING PAPERS
Among those articles to be published in Journal of Automatic Chemistry, Vol. 5, No. 4 (October-December 1983) are"
’Six years’ experience of in-house maintenance on clinical chemistry autoanalysers’ by D. J. Wyper et al. (The authors show
that the in-house scheme run by the West ofScotland Health Boards has been ofconsiderable financial benefit, also ttiat it has
improved technical expertise within the NHS. The scheme is fully costed to allow comparison with commercial alternatives.)
’Automated determination of zinc and copper in plasma’ by B. Sampson. (Estimation of copper and zinc concentrations in
plasma and serum is becoming a commonly requested analysis. The continuous-flow method described is readily adaptable to
most clinical laboratories.)
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